510(k) K000921
K000921 is an FDA 510(k) premarket notification submitted by Bayer Corp. for the device "BAYER ADVIA IMS SYSTEM; 200 + 3". The FDA issued a decision of Substantially Equivalent on May 18, 2000. The device falls under product code DER (Alpha-1-Lipoprotein, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5580. Bayer Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 18, 2000
- Date Received
- March 22, 2000
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Alpha-1-Lipoprotein, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5580
- Review Panel
- IM
- Submission Type